Benzodiazepine Dependence: Clinical Trials

4 trials for Benzodiazepine Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 1, Terminated 1
Phase 31Recruiting 1

Follow Benzodiazepine Dependence: new trials by email Literature Review of Benzodiazepine Dependence trials Research Report on Benzodiazepine Dependence

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence
Baclofen 30 mg, Baclofen 60 mg, Placebo - Benzodiazepine Dependence
Phase 2 / Phase 3RecruitingHospices Civils de Lyon932026-01-152026-05-11
Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT
Oxytocin nasal spray, Saline (NaCl 0,9 %) (placebo) - Benzodiazepine Dependence
Phase 2CompletedSt. Olavs Hospital662022-03-012026-09-28
Gabapentin Treatment of Benzodiazepine Dependence
gabapentin, Placebo - Benzodiazepine Dependence
Phase 2TerminatedNew York State Psychiatric Institute22013-07-012019-04-24
Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients
Gabapentin, Placebo - Benzodiazepine Dependence, Opioid Dependence
Phase 2CompletedNew York State Psychiatric Institute192007-01-012019-04-24

Narrower conditions

Opioid-Related Disorders (1)

Broader conditions

Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Gabapentin (2)  ·  Baclofen (1)  ·  Oxytocin (1)  ·  Sodium Chloride (1)

Sponsors

New York State Psychiatric Institute (2)  ·  Hospices Civils de Lyon (1)  ·  St. Olavs Hospital (1)

Countries

United States (2)  ·  France (1)  ·  Norway (1)

Top investigators

John J Mariani, M.D (1)  ·  John J. Mariani, MD (1)  ·  Olav Spigset, MD, PhD (1)  ·  Tone Aurora Pleym, MD, PhD-candidate (1)

Results publications

PMID 26962719

NIH funding

2019 (1), K23DA021209 (1)